Cutaneous Radiation Injury Treatment Market size is likely to expand at more than 4.5% CAGR during the forecast period i.e., between 2024-2036. The market’s growth can be attributed to growing prevalence of cancer and rising adoption of radiation therapy for the treatment of cancer patients. For instance, as per the statistics by GLOBOCAN, the (5-year) prevalence of cancer was 50,550,287 globally in 2020. Along with this, rising availability of topical creams, increasing healthcare awareness among population, growing geriatric population, and emergence of various online pharmacies is expected to drive the market growth in the upcoming years.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024–2036 |
|
CAGR |
4.5% |
|
Regional Scope |
|
Based on product, the global cutaneous radiation injury treatment market is segmented into topical, dressings, and oral drugs. The topical segment accounted for the largest market size in value in 2021 on account of increasing product launch by various manufacturers across the globe coupled with rising risks of developing radiation burns. On the other hand, the dressing segment is anticipated to grow with the highest CAGR during the forecast period.
On the basis of exposure, the market is segmented into contamination and irradiation, out of which the irradiation segment captured a significant share of the market in 2021. Further, the segment is projected to grow during the forecast period on account of factors, such as increasing number of patients diagnosed with cancer and rising use of radiation therapy for cancer treatment.
Based on stage, the market is classified into prodromal stage, latent stage, manifest illness stage, third wave of erythema, and late effects. Among them, the third wave of erythema segment is anticipated to grab a significant share by 2031 owing to discomforts experienced by the exposed persons during this stage and increasing number of people affected by high grade radiations.
Based on distribution channel, the global cutaneous radiation injury treatment market is segmented into online pharmacy, and offline pharmacy, of which the offline pharmacy segment held the highest share in 2021 on account of growing retail pharmacy and increasing availability of products as offline pharmacy is easily accessible to people.
Our in-depth analysis of the global market includes the following segments:
|
By Product |
|
|
By Exposure |
|
|
By Stage |
|
|
By Distribution Channel |
|
The global cutaneous radiation injury treatment market is segmented into five major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Asia Pacific industry is predicted to hold largest revenue share by 2036, owing to increasing awareness among the population about available treatment for radiation injuries, rising healthcare awareness, and growing cancer incidence. Furthermore, in 2021, the market in North America occupied the largest revenue share, owing to the high prevalence of cancer and presence of leading healthcare service providers in the region. Along with this, North America has an increasingly aging population, which is expected to contribute to the market growth in the upcoming years. As per the Data released by the World Bank, in 2020, the total geriatric population in the USA was 55,131,698.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?